COVID-19.рф: ИНФОРМАЦИЯ ПРОТИВ ПАНДЕМИИ

Поиск по репозиторию

Статья

First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020

G. Spiteri, J. Fielding, M. Diercke, C. Campese, V. Enouf, A. Gaymard, A. Bella, P. Sognamiglio, M. Moros, A. Riutort, Y. Demina, R. Mahieu, M. Broas, M. Bengnér, S. Buda, J. Schilling, L. Filleul, A. Lepoutre, C. Saura, A. Mailles, D. Levy-Bruhl, B. Coignard, S. Bernard-Stoecklin, S. Behillil, D. Van, M. Valette, B. Lina, F. Riccardo, E. Nicastri, I. Casas, A. Larrauri, M. Castell, F. Pozol, R. Maksyutov, C. Martin, M. Ranst, N. Bossuyt, L. Siira, J. Sane, K. Tegmark-Wisell, M. Palmérus, E. Broberg, J. Beauté, P. Jorgensen, N. Bundle, D. Pereyaslov, C. Adlhoch, J. Pukkila, R. Pebody, S. Olsen, B. Ciancio,
2021
https://doi.org/10.2807/1560-7917.ES.2020.25.9.2000178

In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020. We detail the first European cases. As at 21 February, nine European countries reported 47 cases. Among 38 cases studied, 21 were linked to two clusters in Germany and France, 14 were infected in China. Median case age was 42 years; 25 were male. Late detection of the clusters' index cases delayed isolation of further local cases. As at 5 March, there were 4,250 cases. © 2020 European Centre for Disease Prevention and Control (ECDC). All rights reserved.

Цитирование

Похожие публикации

Very little influenza in the WHO European Region during the 2020/21 season, weeks40 2020 to 8 2021
C. Adlhoch, P. Mook, F. Lamb,
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
E. Alm, E. Broberg, T. Connor,
Virological surveillance of influenza viruses in the WHO European Region in 2019/20 - Impact of the COVID-19 pandemic
A. Melidou, D. Pereyaslov, O. Hungnes,

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • G. Spiteri
    European Centre for Disease Prevention and Control, Stockholm, Sweden
  • J. Fielding
    World Health Organisation Regional Office for Europe, Copenhagen, Denmark
  • M. Diercke
    Robert Koch Institute, Berlin, Germany
  • C. Campese
    Santé Publique France - Direction des Maladies Infectieuses, Saint-Maurice, France
  • V. Enouf
    Centre National de Référence Virus des Infections Respiratoires, Dont la Grippe, Institut Pasteur, Paris, France
  • A. Gaymard
    Centre National de Référence Virus des Infections Respiratoires, Dont la Grippe, Hospices Civils de Lyon, Lyon, France
  • A. Bella
    Istituto Superiore di Sanita, Rome, Italy
  • P. Sognamiglio
    Istituto Nazionale Malattie Infettive Lazzaro Spallanzani, Rome, Italy
  • M. Moros
    Coordination Centre for Health Alerts and Emergencies, Spanish Ministry of Health, Madrid, Spain
  • A. Riutort
    Servicio de Epidemiología, Dirección General de Salut Pública, Islas Baleares, Spain
  • Y. Demina
    Fed. Service for Surveillance on Consumer Rights Protection and Human Well-being (Rospotrebnadzor), Moscow, Russian Federation
  • R. Mahieu
    Department of Infectious Disease Prevention and Control, Common Community Commission, Brussels-Capital Region, Brussels, Belgium
  • M. Broas
    Chief Physician, Infection Control Unit, Lapland Hospital District, Rovaniemi, Finland
  • M. Bengnér
    County Medical Officer, Jönköping Region, Jönköping, Sweden
  • S. Buda
    Santé Publique France - Direction des Régions, Cellule Régionale Nouvelle Aquitaine, Bordeaux, France
  • J. Schilling
    Santé Publique France - Direction des Régions, Cellule Régionale Ile-de-France, Paris, France
  • L. Filleul
    Santé Publique France - Direction des Régions, Cellule Régionale Auvergne-Rhône-Alpes, Lyon, France
  • A. Lepoutre
    National Centre for Microbiology, WHO-National Influenza Centre, Institute of Health Carlos Iii, Madrid, Spain
  • C. Saura
    National Centre of Epidemiology, Ciberesp, Institute of Health Carlos Iii, Madrid, Spain
  • A. Mailles
    Dirección General de Salut Pública, Islas Baleares, Spain
  • D. Levy-Bruhl
    State Research Center of Virology and Biotechnology Vector, Rospotrebnadzor, Moscow, Russian Federation
  • B. Coignard
    St. Pierre Hospital, Brussels, Belgium
  • S. Bernard-Stoecklin
    Laboratory of Clinical Virology, Department of Microbiology and Immunology, Rega Institute, Ku Leuven, University of Leuven, Leuven, Belgium
  • S. Behillil
    Epidemiology of Infectious Diseases, Sciensano, Brussels, Belgium
  • D. Van
    Expert Microbiology Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
  • M. Valette
    Infectious Disease Control and Vaccinations Unit, Department of Health Security, Finnish Institute for Health and Welfare (THL), Helsinki, Finland
  • B. Lina
    Public Health Agency of Sweden, Solna, Sweden
  • F. Riccardo
    Jönköping Region, Jönköping, Sweden
  • E. Nicastri
  • I. Casas
  • A. Larrauri
  • M. Castell
  • F. Pozol
  • R. Maksyutov
  • C. Martin
  • M. Ranst
  • N. Bossuyt
  • L. Siira
  • J. Sane
  • K. Tegmark-Wisell
  • M. Palmérus
  • E. Broberg
  • J. Beauté
  • P. Jorgensen
  • N. Bundle
  • D. Pereyaslov
  • C. Adlhoch
  • J. Pukkila
  • R. Pebody
  • S. Olsen
  • B. Ciancio
Название журнала
  • Eurosurveillance
Том
  • 25
Выпуск
  • 9
Страницы
  • -
Ключевые слова
  • RNA directed RNA polymerase; virus nucleoprotein; COVID-19; severe acute respiratory syndrome coronavirus 2; virus envelope protein; age distribution; artificial ventilation; asymptomatic infection; coronavirus disease 2019; Coronavirus infection; disease surveillance; disease transmission; envelope gene; Europe; geographic distribution; hospitalization; human; incidence; incubation time; intensive care; laboratory diagnosis; mortality; N gene; nasopharyngeal aspiration; nonhuman; nose smear; polymerase chain reaction; RdRp gene; Review; SARS-related coronavirus; Severe acute respiratory syndrome coronavirus 2; sex difference; sputum analysis; throat culture; tracheal aspiration procedure; travel; virus pneumonia; World Health Organization; adolescent; adult; aged; Betacoronavirus; child; China; Europe; female; genetics; health survey; isolation and purification; male; middle aged; preschool child; real time polymerase chain reaction; risk factor; very elderly; virus pneumonia; World Health Organization; young adult; Adolescent; Adult; Aged; Aged, 80 and over; Betacoronavirus; Child; Child, Preschool; China; Coronavirus Infections; Europe; Female; Hospitalization; Humans; Male; Middle Aged; Pneumonia, Viral; Population Surveillance; Real-Time Polymerase Chain Reaction; Risk Factors; Travel; Viral Envelope Proteins; World Health Organization; Young Adult
Издатель
  • European Centre for Disease Prevention and Control (ECDC)
Тип документа
  • Review
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus
COVID-19.рф: Информация против пандемии

Адрес: 115114, Москва, ул. Летниковская, д. 4, стр.5, офис 2.4
тел.\факс: +7(499)754-99-94, доб. 502
e-mail: covid19@neicon.ru

Проект реализуется с использованием гранта Президента Российской Федерации на развитие гражданского общества, предоставленного Фондом президентских грантов.

Содержимое сайта, если не указано иное, опубликовано в соответствии с лицензией Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная (CC BY 4.0). Права на материалы, переданные партнерами проекта, принадлежат их правообладателям.

© 2025 NEICON